Advertisement
Original Article| Volume 25, ISSUE 7, P531-536, July 2019

Reduced rates of antimicrobial resistance in Staphylococcus intermedius group and Escherichia coli isolated from diseased companion animals in an animal hospital after restriction of antimicrobial use

  • Goro Kurita
    Correspondence
    Corresponding author. Veterinary Doctor Kurita Animal Hospital, 139-1 Koga, Koga, Ibaraki, 306-0016, Japan.
    Affiliations
    Kurita Animal Hospital, 139-1 Koga, Koga, Ibaraki, 306-0016, Japan

    Laboratory of Infectious Diseases, Kitasato Institute for Life Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan
    Search for articles by this author
  • Yuzo Tsuyuki
    Affiliations
    Division of Clinical Laboratory, Sanritsu Zelkova Veterinary Laboratory, 2-5-8 Kuji, Takatsu-ku, Kawasaki, Kanagawa, 213-0032, Japan

    Laboratory of Infectious Diseases, Kitasato Institute for Life Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan
    Search for articles by this author
  • Yoshiteru Murata
    Affiliations
    Murata Animal Hospital, 2016 Honnou, Mobara, Chiba, 299-4114, Japan

    Laboratory of Infectious Diseases, Kitasato Institute for Life Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan
    Search for articles by this author
  • Takashi Takahashi
    Affiliations
    Laboratory of Infectious Diseases, Kitasato Institute for Life Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan
    Search for articles by this author
  • Veterinary Infection Control Association (VICA) AMR Working Group
Published:March 21, 2019DOI:https://doi.org/10.1016/j.jiac.2019.02.017

      Abstract

      The 2016 National Action Plan aims for reduction in antimicrobial resistance (AMR) to tetracyclines, third-generation cephalosporins, and fluoroquinolones in Escherichia coli isolates from livestock: to lower the tetracycline resistance of E. coli to 33% or less; to maintain the third-generation cephalosporin resistance of E. coli at the same level as in the other G7 countries as of 2020; and to maintain the fluoroquinolone resistance of E. coli at the same level as in the other G7 countries as of 2020. A relatively unexplored facet of reducing AMR is the impact of minimizing transmission of AMR strains by companion animals. In this study we compared AMR rates in Staphylococcus intermedius group (SIG) and E. coli isolated from diseased companion animals in an animal hospital before and after restriction of antimicrobial use. Our study spanned a 4.5-year period from 2014 to June 2018 during which antimicrobial use was restricted in 2016. During this period, abundance of methicillin-resistant SIG isolates from the hospital dropped from 41.5% to 9.3%, and that of extended-spectrum β-lactamase (ESBL)-producing E. coli isolates dropped from 29.5% to 9.5%. Tests for antimicrobial susceptibility revealed significantly reduced rates of AMR to enrofloxacin and levofloxacin in SIG isolates, and to cefazolin in E. coli isolates after antimicrobial use was restricted. Our observations suggest that restriction of antimicrobial use, especially that of third-generation cephalosporins and fluoroquinolones, is an effective method for reducing AMR rates. These findings will be relevant in guiding antimicrobial restriction approaches in other animal hospitals and clinics.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Infection and Chemotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Anicom
        White paper on household animals.
        2016 ([in Japanese])
        • Centers for Disease Control and Prevention
        One health.
        https://www.cdc.gov/onehealth/index.html
        Date accessed: November 16, 2018
        • Tsuyuki Y.
        • Kurita G.
        • Murata Y.
        • Takahashi T.
        Bacteria isolated from companion animals in Japan (2014-2016) by blood culture.
        J Infect Chemother. 2018; 24: 583-587
        • Tsuyuki Y.
        • Takahashi T.
        Isolated bacteria and their antimicrobial susceptibility through urine culture obtained from companion animals in Japan.
        Kansenshogaku Zasshi. 2017; 91 ([in Japanese]): 392-398
      1. National action plan on antimicrobial resistance 20162020. 5 April 2016 ([in Japanese])
        • Tsuyuki Y.
        • Kurita G.
        • Murata Y.
        • Goto M.
        • Takahashi T.
        Identification of group G streptococcal isolates from companion animals in Japan and their antimicrobial resistance patterns.
        Jpn J Infect Dis. 2017; 70: 394-398
        • Fukushima Y.
        • Tsuyuki Y.
        • Goto M.
        • Yoshida H.
        • Takahashi T.
        Species identification of β-hemolytic streptococci from diseased companion animals and their antimicrobial resistance data in Japan.
        Jpn J Infect Dis. 2018; 72 ([Epub ahead of print])https://doi.org/10.7883/yoken.JJID.2018.231
        • Kurita G.
        Selection of antimicrobials.
        in: Association of antimicrobials for animals, editor. urinary tract infections in dogs and cats: clinical manual. Interzoo, Tokyo2017: 12-18 ([in Japanese])
        • Kurita G.
        Two cases of dogs with pyotraumatic dermatitis successfully treated without antimicrobial use.
        Small Anim Dermatol. 2018; 14 ([in Japanese]): 87-94
        • He Q.
        • Chen W.
        • Huang L.
        • Lin Q.
        • Zhang J.
        • Liu R.
        • et al.
        Performance evaluation of three automated identification systems in detecting carbapenem-resistant Enterobacteriaceae.
        Ann Clin Microbiol Antimicrob. 2016; 15: 40
        • CLSI
        Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement M100–S18.
        Clinical and Laboratory Standards Institute, Wayne, PA, USA2008
        • CLSI
        Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement M100–S22.
        Clinical and Laboratory Standards Institute, Wayne, PA, USA2012
        • CLSI
        Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals—second edition VET01–S2.
        Clinical and Laboratory Standards Institute, Wayne, PA, USA2013
        • Devriese L.A.
        • Vancanneyt M.
        • Baele M.
        • Vaneechoutte M.
        • De Graef E.
        • Snauwaert C.
        • et al.
        Staphylococcus pseudintermedius sp. nov., a coagulase-positive species from animals.
        Int J Syst Evol Microbiol. 2005; 55: 1569-1573
        • Danish Small Animal Veterinary Association
        Antibiotic use guidelines for companion animal practice.
        2012
        • van Duijkeren E.
        • Catry B.
        • Greko C.
        • Moreno M.A.
        • Pomba M.C.
        • Pyörälä S.
        • et al.
        Review on methicillin-resistant Staphylococcus pseudintermedius.
        J Antimicrob Chemother. 2011; 66: 2705-2714
        • Saputra S.
        • Jordan D.
        • Worthing K.A.
        • Norris J.M.
        • Wong H.S.
        • Abraham R.
        • et al.
        Antimicrobial resistance in coagulase-positive staphylococci isolated from companion animals in Australia: a one year study.
        PLoS One. 2017; 12e0176379
        • Gandolfi-Decristophoris P.
        • Petrini O.
        • Ruggeri-Bernardi N.
        • Schelling E.
        Extended-spectrum β-lactamase-producing Enterobacteriaceae in healthy companion anismals living in nursing homes and in the community.
        Am J Infect Contr. 2013; 41: 831-835
        • Baede V.O.
        • Broens E.M.
        • Spaninks M.P.
        • Timmerman A.J.
        • Graveland H.
        • Wagenaar J.A.
        • et al.
        Raw pet food as a risk factor for shedding of extended-spectrum beta-lactamase-producing Enterobacteriaceae in household cats.
        PLoS One. 2017; 12e0187239